Genome Sequencing Service - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512247447

Publication Date:

December 4, 2024

Pages:

169

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Genome Sequencing Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Genome Sequencing Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genome Sequencing Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Genome Sequencing Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Genome Sequencing Service include Illumina, Thermo Fisher Scientific, BGI Genomics, Agilent Technologies, 10X Genomics, QIAGEN, GENEWIZ, Macrogen and GE Healthcare Life Sciences, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genome Sequencing Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Genome Sequencing Service by region & country, by Type, and by Application.
The Genome Sequencing Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genome Sequencing Service.
麻豆原创 Segmentation
By Company
Illumina
Thermo Fisher Scientific
BGI Genomics
Agilent Technologies
10X Genomics
QIAGEN
GENEWIZ
Macrogen
GE Healthcare Life Sciences
Johnson & Johnson
Abbott Laboratories
Bayer
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Novogene
Eurofins Genomics
Psomagen
Segment by Type:
Whole-Genome Sequencing
Whole exome Sequencing
Segment by Application
Humanity
Plant
Animal
Microorganism
Virus
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Genome Sequencing Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Genome Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Genome Sequencing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Genome Sequencing Service Product Introduction
1.2 Global Genome Sequencing Service 麻豆原创 Size Forecast
1.3 Genome Sequencing Service 麻豆原创 Trends & Drivers
1.3.1 Genome Sequencing Service Industry Trends
1.3.2 Genome Sequencing Service 麻豆原创 Drivers & Opportunity
1.3.3 Genome Sequencing Service 麻豆原创 Challenges
1.3.4 Genome Sequencing Service 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Genome Sequencing Service Players Revenue Ranking (2023)
2.2 Global Genome Sequencing Service Revenue by Company (2019-2024)
2.3 Key Companies Genome Sequencing Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Genome Sequencing Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Genome Sequencing Service
2.6 Genome Sequencing Service 麻豆原创 Competitive Analysis
2.6.1 Genome Sequencing Service 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Genome Sequencing Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome Sequencing Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Whole-Genome Sequencing
3.1.2 Whole exome Sequencing
3.2 Global Genome Sequencing Service Sales Value by Type
3.2.1 Global Genome Sequencing Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Genome Sequencing Service Sales Value, by Type (2019-2030)
3.2.3 Global Genome Sequencing Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Humanity
4.1.2 Plant
4.1.3 Animal
4.1.4 Microorganism
4.1.5 Virus
4.2 Global Genome Sequencing Service Sales Value by Application
4.2.1 Global Genome Sequencing Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Genome Sequencing Service Sales Value, by Application (2019-2030)
4.2.3 Global Genome Sequencing Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Genome Sequencing Service Sales Value by Region
5.1.1 Global Genome Sequencing Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Genome Sequencing Service Sales Value by Region (2019-2024)
5.1.3 Global Genome Sequencing Service Sales Value by Region (2025-2030)
5.1.4 Global Genome Sequencing Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Genome Sequencing Service Sales Value, 2019-2030
5.2.2 North America Genome Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Genome Sequencing Service Sales Value, 2019-2030
5.3.2 Europe Genome Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Genome Sequencing Service Sales Value, 2019-2030
5.4.2 Asia Pacific Genome Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Genome Sequencing Service Sales Value, 2019-2030
5.5.2 South America Genome Sequencing Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Genome Sequencing Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Genome Sequencing Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Genome Sequencing Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Genome Sequencing Service Sales Value
6.3 United States
6.3.1 United States Genome Sequencing Service Sales Value, 2019-2030
6.3.2 United States Genome Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Genome Sequencing Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Genome Sequencing Service Sales Value, 2019-2030
6.4.2 Europe Genome Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Genome Sequencing Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Genome Sequencing Service Sales Value, 2019-2030
6.5.2 China Genome Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Genome Sequencing Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Genome Sequencing Service Sales Value, 2019-2030
6.6.2 Japan Genome Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Genome Sequencing Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Genome Sequencing Service Sales Value, 2019-2030
6.7.2 South Korea Genome Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Genome Sequencing Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Genome Sequencing Service Sales Value, 2019-2030
6.8.2 Southeast Asia Genome Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Genome Sequencing Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Genome Sequencing Service Sales Value, 2019-2030
6.9.2 India Genome Sequencing Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Genome Sequencing Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Profile
7.1.2 Illumina Main Business
7.1.3 Illumina Genome Sequencing Service Products, Services and Solutions
7.1.4 Illumina Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.1.5 Illumina Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Genome Sequencing Service Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 BGI Genomics
7.3.1 BGI Genomics Profile
7.3.2 BGI Genomics Main Business
7.3.3 BGI Genomics Genome Sequencing Service Products, Services and Solutions
7.3.4 BGI Genomics Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.3.5 Agilent Technologies Recent Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Profile
7.4.2 Agilent Technologies Main Business
7.4.3 Agilent Technologies Genome Sequencing Service Products, Services and Solutions
7.4.4 Agilent Technologies Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.4.5 Agilent Technologies Recent Developments
7.5 10X Genomics
7.5.1 10X Genomics Profile
7.5.2 10X Genomics Main Business
7.5.3 10X Genomics Genome Sequencing Service Products, Services and Solutions
7.5.4 10X Genomics Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.5.5 10X Genomics Recent Developments
7.6 QIAGEN
7.6.1 QIAGEN Profile
7.6.2 QIAGEN Main Business
7.6.3 QIAGEN Genome Sequencing Service Products, Services and Solutions
7.6.4 QIAGEN Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.6.5 QIAGEN Recent Developments
7.7 GENEWIZ
7.7.1 GENEWIZ Profile
7.7.2 GENEWIZ Main Business
7.7.3 GENEWIZ Genome Sequencing Service Products, Services and Solutions
7.7.4 GENEWIZ Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.7.5 GENEWIZ Recent Developments
7.8 Macrogen
7.8.1 Macrogen Profile
7.8.2 Macrogen Main Business
7.8.3 Macrogen Genome Sequencing Service Products, Services and Solutions
7.8.4 Macrogen Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.8.5 Macrogen Recent Developments
7.9 GE Healthcare Life Sciences
7.9.1 GE Healthcare Life Sciences Profile
7.9.2 GE Healthcare Life Sciences Main Business
7.9.3 GE Healthcare Life Sciences Genome Sequencing Service Products, Services and Solutions
7.9.4 GE Healthcare Life Sciences Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.9.5 GE Healthcare Life Sciences Recent Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Profile
7.10.2 Johnson & Johnson Main Business
7.10.3 Johnson & Johnson Genome Sequencing Service Products, Services and Solutions
7.10.4 Johnson & Johnson Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.10.5 Johnson & Johnson Recent Developments
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Profile
7.11.2 Abbott Laboratories Main Business
7.11.3 Abbott Laboratories Genome Sequencing Service Products, Services and Solutions
7.11.4 Abbott Laboratories Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.11.5 Abbott Laboratories Recent Developments
7.12 Bayer
7.12.1 Bayer Profile
7.12.2 Bayer Main Business
7.12.3 Bayer Genome Sequencing Service Products, Services and Solutions
7.12.4 Bayer Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.12.5 Bayer Recent Developments
7.13 Microchip Biotechnologies
7.13.1 Microchip Biotechnologies Profile
7.13.2 Microchip Biotechnologies Main Business
7.13.3 Microchip Biotechnologies Genome Sequencing Service Products, Services and Solutions
7.13.4 Microchip Biotechnologies Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.13.5 Microchip Biotechnologies Recent Developments
7.14 Myriad Genetics
7.14.1 Myriad Genetics Profile
7.14.2 Myriad Genetics Main Business
7.14.3 Myriad Genetics Genome Sequencing Service Products, Services and Solutions
7.14.4 Myriad Genetics Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.14.5 Myriad Genetics Recent Developments
7.15 Commonwealth Biotechnologies
7.15.1 Commonwealth Biotechnologies Profile
7.15.2 Commonwealth Biotechnologies Main Business
7.15.3 Commonwealth Biotechnologies Genome Sequencing Service Products, Services and Solutions
7.15.4 Commonwealth Biotechnologies Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.15.5 Commonwealth Biotechnologies Recent Developments
7.16 ZS Genetics
7.16.1 ZS Genetics Profile
7.16.2 ZS Genetics Main Business
7.16.3 ZS Genetics Genome Sequencing Service Products, Services and Solutions
7.16.4 ZS Genetics Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.16.5 ZS Genetics Recent Developments
7.17 Pacific Biosciences
7.17.1 Pacific Biosciences Profile
7.17.2 Pacific Biosciences Main Business
7.17.3 Pacific Biosciences Genome Sequencing Service Products, Services and Solutions
7.17.4 Pacific Biosciences Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.17.5 Pacific Biosciences Recent Developments
7.18 Novogene
7.18.1 Novogene Profile
7.18.2 Novogene Main Business
7.18.3 Novogene Genome Sequencing Service Products, Services and Solutions
7.18.4 Novogene Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.18.5 Novogene Recent Developments
7.19 Eurofins Genomics
7.19.1 Eurofins Genomics Profile
7.19.2 Eurofins Genomics Main Business
7.19.3 Eurofins Genomics Genome Sequencing Service Products, Services and Solutions
7.19.4 Eurofins Genomics Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.19.5 Eurofins Genomics Recent Developments
7.20 Psomagen
7.20.1 Psomagen Profile
7.20.2 Psomagen Main Business
7.20.3 Psomagen Genome Sequencing Service Products, Services and Solutions
7.20.4 Psomagen Genome Sequencing Service Revenue (US$ Million) & (2019-2024)
7.20.5 Psomagen Recent Developments
8 Industry Chain Analysis
8.1 Genome Sequencing Service Industrial Chain
8.2 Genome Sequencing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Genome Sequencing Service Sales Model
8.5.2 Sales Channel
8.5.3 Genome Sequencing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Illumina
Thermo Fisher Scientific
BGI Genomics
Agilent Technologies
10X Genomics
QIAGEN
GENEWIZ
Macrogen
GE Healthcare Life Sciences
Johnson & Johnson
Abbott Laboratories
Bayer
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Novogene
Eurofins Genomics
Psomagen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.